Published in Gynecol Endocrinol on October 01, 2007
Estrogen, cognition and female ageing. Hum Reprod Update (2006) 1.78
Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens (2003) 1.49
Non-genomic actions of sex steroid hormones. Eur J Endocrinol (2003) 1.48
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application. Menopause (2007) 1.47
Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway. Mol Endocrinol (2006) 1.35
Genomic and non-genomic effects of estrogens on endothelial cells. Steroids (2004) 1.20
Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion. PLoS One (2008) 1.14
Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation (2002) 1.11
Influence of endogenous and exogenous sex hormones on plasma brain-derived neurotrophic factor. Hum Reprod (2007) 1.08
Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol (2008) 1.08
Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton. PLoS One (2008) 1.08
Kallmann syndrome in women: from genes to diagnosis and treatment. Gynecol Endocrinol (2013) 1.02
Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology (2010) 0.98
Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor alpha with phosphatidylinositol 3-OH kinase. Steroids (2002) 0.98
Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase. Endocr Relat Cancer (2010) 0.97
Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology (2003) 0.97
Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology (2004) 0.96
Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. J Clin Endocrinol Metab (2008) 0.95
Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels. Fertil Steril (2008) 0.95
Compensatory feto-placental upregulation of the nitric oxide system during fetal growth restriction. PLoS One (2012) 0.95
Rapid signaling of estrogen to WAVE1 and moesin controls neuronal spine formation via the actin cytoskeleton. Mol Endocrinol (2009) 0.95
Endocrinology of menopausal transition and its brain implications. CNS Spectr (2005) 0.93
Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin. Mol Hum Reprod (2008) 0.90
Perception and reality in a case of suspected cervical fracture. Rays (2006) 0.88
Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF. J Assist Reprod Genet (2008) 0.88
P53 gene status in patients with advanced serous epithelial ovarian cancer in relation to response to paclitaxel- plus platinum-based chemotherapy and long-term clinical outcome. Anticancer Res (2006) 0.87
Effects of low-dose, continuous combined estradiol and noretisterone acetate on menopausal quality of life in early postmenopausal women. Maturitas (2003) 0.87
Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecol Endocrinol (2009) 0.86
Rapid estrogen actions in the cardiovascular system. Ann N Y Acad Sci (2006) 0.86
Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptive-induced menstrual migraine: a pilot study. Gynecol Endocrinol (2010) 0.86
Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol (2006) 0.85
Endometriosis-Associated Abdominal Wall Cancer: A Poor Prognosis? Int J Gynecol Cancer (2015) 0.84
Genomic and nongenomic mechanisms of nitric oxide synthesis induction in human endothelial cells by a fourth-generation selective estrogen receptor modulator. Endocrinology (2002) 0.84
Might DHEA be considered a beneficial replacement therapy in the elderly? Drugs Aging (2007) 0.83
Pregnancy complications in polycystic ovary syndrome patients. Gynecol Endocrinol (2014) 0.83
Long-term low-dose dehydroepiandrosterone oral supplementation in early and late postmenopausal women modulates endocrine parameters and synthesis of neuroactive steroids. Fertil Steril (2003) 0.83
Self-reported sexual symptoms in women attending menopause clinics. Gynecol Obstet Invest (2002) 0.83
Sex steroids and breast cancer metastasis. Horm Mol Biol Clin Investig (2010) 0.82
Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Neuroendocrinology (2006) 0.82
Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism. Maturitas (2006) 0.82
Effects of low-dose, continuous combined hormone replacement therapy on sleep in symptomatic postmenopausal women. Maturitas (2005) 0.81
Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphin. Fertil Steril (2005) 0.81
Effects of oral contraceptives on bone mineral density. Treat Endocrinol (2004) 0.81
Pulsatile secretory characteristics of allopregnanolone, a neuroactive steroid, during the menstrual cycle and in amenorrheic subjects. Eur J Endocrinol (2002) 0.81
Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause (2005) 0.80
Serum allopregnanolone levels relate to FSFI score during the menstrual cycle. J Sex Marital Ther (2003) 0.80
Circulating levels of neuroactive steroids in patients with binge eating disorder: a comparison with nonobese healthy controls and non-binge eating obese subjects. Int J Eat Disord (2003) 0.80
Effects of phytoestrogens derived from red clover on atherogenic adhesion molecules in human endothelial cells. Menopause (2008) 0.80
Androgens and the brain. Maturitas (2007) 0.80
Membrane integrity evaluation in rabbit spermatozoa. Eur J Obstet Gynecol Reprod Biol (2002) 0.80
Effect of tibolone administration on central and peripheral levels of allopregnanolone and beta-endorphin in female rats. Menopause (2006) 0.80
In vitro effects of progesterone and progestins on vascular cells. Steroids (2003) 0.80
Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome. Gynecol Endocrinol (2006) 0.80
The metabolic syndrome and its components in postmenopausal women. Gynecol Endocrinol (2013) 0.80
Anomalous origin of the coronary arteries in children: diagnostic role of three-dimensional coronary MR angiography. Clin Imaging (2010) 0.80
Conjugated equine estrogens, estrone sulphate and estradiol valerate oral administration in ovariectomized rats: effects on central and peripheral allopregnanolone and beta-endorphin. Maturitas (2002) 0.79
Effects of nomegestrol acetate administration on central and peripheral beta-endorphin and allopregnanolone in ovx rats. J Steroid Biochem Mol Biol (2008) 0.79
Assessment of insomnia and related risk factors in postmenopausal women screened for the metabolic syndrome. Maturitas (2012) 0.79
Homocysteine, menopause and cardiovascular disease. Menopause Int (2007) 0.79
One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. Maturitas (2007) 0.79
Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk. Maturitas (2005) 0.79
Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med (2012) 0.79
Estrogen-like effects of wine extracts on nitric oxide synthesis in human endothelial cells. Maturitas (2011) 0.79
Hormone therapy. Menopause (2003) 0.78
Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrodydrogesterone, on nitric oxide synthesis in human endothelial cells. Fertil Steril (2006) 0.78
Skeletal status and body composition in young women with functional hypothalamic amenorrhea. Gynecol Endocrinol (2011) 0.78
Paroxetine increases brain-derived neurotrophic factor in postmenopausal women. Menopause (2010) 0.78
Subtotal versus total laparoscopic hysterectomy: could women sexual function recovery overcome the surgical outcomes in pre-operatory decision making? Arch Gynecol Obstet (2014) 0.78
The latest elaboration of the Women's Health Initiative data on hormone replacement therapy and cardiovascular disease in postmenopausal women. Gynecol Endocrinol (2007) 0.77
A randomized control comparison study of culture media (HTF versus P1) for human in vitro fertilization. Eur J Obstet Gynecol Reprod Biol (2004) 0.77
Pharmacotherapy: Benefits of menopausal hormone therapy--timing is key. Nat Rev Endocrinol (2012) 0.77
Tibolone activates nitric oxide synthesis in human endothelial cells. J Clin Endocrinol Metab (2004) 0.77
Differential estrogen signaling in endothelial cells upon pulsed or continuous administration. Maturitas (2005) 0.77
Drospirenone increases central and peripheral beta-endorphin in ovariectomized female rats. Menopause (2007) 0.76
Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women. Neuropsychiatr Dis Treat (2006) 0.76
[Cardiovascular effects of selective estrogen receptor modulators. Current perspectives]. Recenti Prog Med (2003) 0.76
Clinical evaluation of patients with weight loss-related amenorrhea: neuropeptide Y and luteinizing hormone pulsatility. Gynecol Endocrinol (2006) 0.76
Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial. Maturitas (2002) 0.76
Clinical relevance of the HERS trial. Lancet (2002) 0.76
Activation of nitric oxide synthesis in human endothelial cells using nomegestrol acetate. Obstet Gynecol (2006) 0.76
One-year therapy with 10mg/day DHEA alone or in combination with HRT in postmenopausal women: effects on hormonal milieu. Maturitas (2008) 0.76
Diurnal Variation of Plasma Brain-Derived Neurotrophic Factor Levels in Women with Functional Hypothalamic Amenorrhea. Neuroendocrinology (2015) 0.76
Nitric oxide and pro-inflammatory cytokine serum levels in postmenopausal women with the metabolic syndrome. Gynecol Endocrinol (2012) 0.76
Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecol Endocrinol (2010) 0.76
When hormone therapy sneaks under your nose. Menopause (2008) 0.75
Estrogen regulates endothelial migration via plasminogen activator inhibitor (PAI-1). Mol Hum Reprod (2012) 0.75
Dehydroepiandrosterone, the endothelium, and cardiovascular protection. Endocrinology (2007) 0.75